Cross-clade recognition and neutralization by the V3 region from clade C human immunodeficiency virus-1 envelope

被引:34
|
作者
Wu, Lan
Yang, Zhi-Yong
Xu, Ling
Welcher, Brent
Winfrey, Sarah
Shao, Yiming
Mascola, John R.
Nabel, Gary J.
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] China CDC, Natl Ctr AIDS STD Control & Prevent, Beijing 100050, Peoples R China
关键词
HIV-1; envelope; neutralizing antibodies;
D O I
10.1016/j.vaccine.2006.03.083
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To understand the cross-reactivity of antibodies directed against variable regions of human immunodeficiency virus-1 (HIV-1) envelope (Env), chimeric immunogens were prepared from different clades with modifications in variable regions, and the resulting neutralizing antibody response was evaluated. The V3-specific neutralization activity induced by a clade B immunogen was limited to clade B viruses and was blocked by a clade B V3 peptide, but not by analogous clade A or C V3 peptides. In contrast, the V3 response elicited by a clade C immunogen cross-reacted with sensitive clade B viruses. The V3 region from a clade C virus, when introduced into a clade B sequence, elicited cross-clade activity, which could be reversed by V3 peptides derived from clades A and C. Thus, the anti-V3 antibody response elicited by a clade C immunogen could cross-react with heterologous clade viruses. Additionally, we describe a V I-specific immune response that mediated neutralization limited to the homologous HIV IIIB isolate and may be partially responsible for the commonly observed strain-specific neutralization responses elicited by vaccine immunogens. Published by Elsevier Ltd.
引用
收藏
页码:4995 / 5002
页数:8
相关论文
共 50 条
  • [1] Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
    Binley, JA
    Wrin, T
    Korber, B
    Zwick, MB
    Wang, M
    Chappey, C
    Stiegler, G
    Kunert, R
    Zolla-Pazner, S
    Katinger, H
    Petropoulos, CJ
    Burton, DR
    JOURNAL OF VIROLOGY, 2004, 78 (23) : 13232 - 13252
  • [2] Human immunodeficiency virus-specific responses in adult Ugandans: Patterns of cross-clade recognition
    Barugahare, B
    Baker, C
    K'Aluoch, O
    Donovan, R
    Elrefaei, M
    Eggena, M
    Jones, N
    Mutalya, S
    Kityo, C
    Mugyenyi, P
    Cao, HY
    JOURNAL OF VIROLOGY, 2005, 79 (07) : 4132 - 4139
  • [3] ANALYSIS OF CROSS-CLADE NEUTRALIZATION BY HIV-1+ HUMAN SERA
    CAO, YZ
    MOORE, J
    LEU, J
    HO, DD
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 217 - 217
  • [4] Antibodies that are cross-reactive for human immunodeficiency virus type 1 clade A and clade B V3 domains are common in patient sera from cameroon, but their neutralization activity is usually restricted by epitope masking
    Krachmarov, C
    Pinter, A
    Honnen, WJ
    Gorny, MK
    Nyambi, PN
    Zolla-Pazner, S
    Kayman, SC
    JOURNAL OF VIROLOGY, 2005, 79 (02) : 780 - 790
  • [5] Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to neutralization during clade C infection
    Rong, Rong
    Bibollet-Ruche, Frederic
    Mulenga, Joseph
    Allen, Susan
    Blackwell, Jerry L.
    Derdeyn, Cynthia A.
    JOURNAL OF VIROLOGY, 2007, 81 (03) : 1350 - 1359
  • [6] The cross-clade neutralizing activity of a human monoclonal antibody is determined by the GPGR V3 motif of HIV type 1
    Zolla-Pazner, S
    Zhong, P
    Revesz, K
    Volsky, B
    Williams, C
    Nyambi, P
    Gorny, MK
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (11) : 1254 - 1258
  • [7] Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH
    Malm, M
    Rollman, E
    Ustav, M
    Hinkula, J
    Krohn, K
    Wahren, B
    Blazevic, V
    VIRAL IMMUNOLOGY, 2005, 18 (04) : 678 - 688
  • [8] Cross-clade neutralization analysis of plasmas from clade B, C and CRF01_AE HIV-infected donors
    Binley, J.
    Wrin, T.
    Pantophlet, R.
    Phung, P.
    Crooks, E. T.
    Lapedes, A.
    Taylor, N.
    Cavacini, L.
    Steigler, G.
    Kunert, R.
    Katinger, H.
    Petropoulos, C.
    Richman, D.
    Morris, L.
    Sutthent, R.
    Burton, D. R.
    RETROVIROLOGY, 2009, 6
  • [9] CROSS-CLADE NEUTRALIZATION OF PRIMARY ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY HUMAN MONOCLONAL-ANTIBODIES AND TETRAMERIC CD4-IGG
    TRKOLA, A
    POMALES, AB
    YUAN, H
    KORBER, B
    MADDON, PJ
    ALLAWAY, GP
    KATINGER, H
    BARBAS, CF
    BURTON, DR
    HO, DD
    MOORE, JP
    JOURNAL OF VIROLOGY, 1995, 69 (11) : 6609 - 6617
  • [10] Cross-clade inhibition of human immunodeficiency virus type 1 primary isolates by monoclonal anti-CD4
    Shearer, MH
    Timanus, DK
    Benton, PA
    Lee, DR
    Kennedy, RC
    JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (06): : 1727 - 1729